Therapeutic cancer vaccination against telomerase: clinical developments in melanoma

Checkpoint inhibitors (CPIs) have revolutionized treatment outcomes for patients with malignant melanoma. Long-term follow-up shows that a substantial subset of patients who exhibit clinical responses achieve extended overall survival. Nevertheless, most patients do not achieve durable benefit from...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellingsen, Espen Basmo, Bjørheim, Jens, Gaudernack, Gustav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
MELANOMA AND OTHER SKIN NEOPLASMS: Edited by Oliver Bechter and Gil Awada
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894137/
https://www.ncbi.nlm.nih.gov/pubmed/36700456
http://dx.doi.org/10.1097/CCO.0000000000000922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894137/
https://www.ncbi.nlm.nih.gov/pubmed/36700456
http://dx.doi.org/10.1097/CCO.0000000000000922

Ejemplares similares